Investing.com -- Shares of Axsome Therapeutics (NASDAQ: AXSM) fell 5.5% following the announcement of its phase 3 trial results for Solriamfetol in adults with ADHD, which achieved its primary ...
Neurocrine (NBIX) presented new data from the long-term, open-label KINECT 4 study demonstrating remission of tardive dyskinesia among the ...
Equities research analysts at Scotiabank issued their FY2026 earnings per share estimates for Magna International in a research report issued to clients and investors on Wednesday, March 19th.
Following on from the successful TC, the MG TD arrived in 1949, introducing some much-needed post-war refinements. Sharper handling and smoother riding than its T-series predecessors, the newcomer ...
Eli Lilly and Company (NYSE: LLY) will participate in TD Cowen's 45th Annual Health Care ... in China has approved Kisunlaâ„¢ (donanemab-azbt, 350 mg/20 mL every four weeks injection for IV ...
In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Roivant Sciences (ROIV – Research Report). The company’s ...
The Toronto-Dominion Bank, together with its subsidiaries, provides various financial products and services in Canada, the United States, and internationally. It operates through four segments ...
MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results